50 rack ORIGINAL UDEN'S First Quarter FY 2025 Results August 8th, 2024 HEALTHCARE ('D) summe eve KILLS Fleet DVANCED CLEAN ULTIMATE ENSITIVE EYES Safe Harbor Disclosure This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, organic revenue growth, adjusted diluted EPS, and free cash flow; the Company's ability to execute on its br ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission File Number: 001-32433 PrestigeConsumer HEALTHCARE PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Cha ...

Exhibit 99.1 Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results ◦ Revenue of $267.1 Million in Q1, Ahead of Expectations ◦ EPS of $0.98 and Adjusted EPS of $0.90 in Q1 ◦ Cash from Operations of $54.8 Million up 13.9% versus Prior Year; Reduced Debt by $35 Million and Repurchased $26 Million Shares ◦ Reaffirming Full-Year Fiscal 2025 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-August 8, 2024-- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported ...

TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate ...

Prestige Consumer Healthcare Inc. (PBH) delivered fourth-quarter fiscal 2024 earnings per share (EPS) of $1.02, a 4.7% decline from the year-ago period's figure. The metric also missed the Zacks Consensus Estimate by 10.5%. GAAP EPS for the quarter was 98 cents, a significant improvement from the year-ago loss of $4.78 per share. For the full year, adjusted EPS was $4.21, flat year over year. Revenues Total revenues in the fiscal fourth quarter declined 3.1% year over year (down 2.9% on an organic basis) to ...

Prestige Consumer Healthcare Inc (NYSE:PBH) Q4 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Phil Terpolilli - Director of Investor Relations Ron Lombardi - Chairman, President & CEO Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Mitchell Pinheiro - Sturdivant Linda Bolton-Weiser - D.A. Davidson Operator Thank you for standing by. My name is Romainy, and I'll prepare your conference operator today. At this ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______ Commission File Number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Inco ...

Prestige Consumer Healthcare (PBH) reported $276.99 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 3.1%. EPS of $1.02 for the same period compares to $1.07 a year ago. View all Key Company Metrics for Prestige Consumer Healthcare here>>> Shares of Prestige Consumer Healthcare have returned +3.5% over the past month versus the Zacks S&P 500 composite's +2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader mark ...

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -10.53%. A quarter ago, it was expected that this medicine distributor would post earnings of $1.04 per share when it actually produced earnings of $1.06, delivering a surprise of 1.92%. Over the last ...

Fourth Fiscal Quarter Ended March 31, 2024 Reported revenues in the fourth quarter of fiscal 2024 of $277.0 million compared to $285.9 million in the fourth quarter of fiscal 2023. Revenues decreased 2.9% excluding the impact of foreign currency. The revenue decline in the quarter was attributable to the inability to supply customer orders late in the quarter in certain brands, the strategic exit of private label revenues, and a lower Women's Health category, partially offset by growth in the International ...